Clinical Trials Browser

Phase 1 × INDUSTRY × resiniferatoxin × Clear all

NCT03226574 2020-10-20

Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain

Phase 1 Completed

Cancer Pain